Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers [Phase 4]
Phase 4 update on the use of INTEGRA Flowable Wound Matrix for diabetic foot ulcers. The trial was terminated and results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Chinese Community Smoking Cessation Project [NA]
A completed clinical trial update for a UCSF-sponsored smoking cessation project conducted in China, listing cardiovascular diseases, heart …
-
CLINICAL_TRIALS withdrawal · 2014-03-13Clinical Trial Update: Metabolic Effects of Antipsychotic Substitution in Children [Phase 2, Phase 3]
A Phase 2/Phase 3 trial examining metabolic effects of switching antipsychotics in children has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy [Phase 2]
A Phase 2 trial update examining whether autonomic neuropathy affects the efficacy of vildagliptin (Galvus) in people with diabetes mellitus…
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg [Phase 1]
Phase 1 study comparing pharmacokinetics of HCP1201 alone versus co-administration with metformin SR 500mg and rosuvastatin 10mg in diabetes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg [Phase 1]
Phase 1 PK study comparing HCP1201 alone versus co-administration with Metformin SR 750mg and Rosuvastatin 10mg for Diabetes Mellitus; the s…
-
FDA approval · 2014-03-04FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly, updating the product under an existing biologics license.
-
FDA approval · 2014-03-04FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin 70/30 (insulin human) by Eli Lilly and Company.
-
FDA approval · 2014-03-04FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approves a supplemental application for HUMULIN N (insulin human) from Eli Lilly, indicating an approved change to the product's labelin…
-
FDA approval · 2014-03-04FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2014-03-04FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The approval covers changes to the product's lab…
-
FDA approval · 2014-02-26FDA Approved: VASCEPA — Supplemental Application (Amarin Pharma Inc.)
FDA approves a supplemental application for Vascepa (icosapent ethyl), expanding its labeling to address cardiovascular risk reduction in ad…
-
CLINICAL_TRIALS research · 2014-02-20Clinical Trial Update: Heart Failure in the Community
Mayo Clinic conducted a clinical trial on heart failure in the community that has completed; the provided snippet does not include trial res…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Full-mouth and Partial-mouth Scaling and Root Planing in Type 2 Diabetic Subjects [Phase 4]
A Phase 4 trial evaluating full-mouth and partial-mouth scaling and root planing in adults with periodontitis and diabetes has completed.
-
CLINICAL_TRIALS research · 2014-02-12Clinical Trial Update: Cost-effectiveness of In-shoe Pressure Measurement for Therapeutic Shoes [NA]
A clinical trial update examining the cost-effectiveness of in-shoe pressure measurement to guide therapeutic footwear for people with diabe…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Expanding Comparative Effectiveness Research (CER) Capability Through Complex Patient Relationship Management [NA]
A completed clinical trial update describes expanding comparative effectiveness research capabilities through complex patient relationship m…
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Reversal of Neuromuscular Blockade in Diabetic Patients
Clinical trial update describing results on reversal of neuromuscular blockade in diabetic patients. The study conducted at Duzce University…
-
CLINICAL_TRIALS trial_result · 2014-02-06Clinical Trial Update: Coronary Artery Revascularization in Diabetes [Phase 4]
Phase 4 trial evaluating coronary artery revascularization in people with diabetes was terminated and results were posted in February 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: RCT of SMS for Drivers With Pre-DM [NA]
A completed randomized controlled trial evaluating an SMS-based intervention for drivers with prediabetes to prevent progression to diabetes…
-
CLINICAL_TRIALS research · 2014-02-05Clinical Trial Update: Soluble Fibre Enriched CHO Food Study [NA]
This is a clinical trial update for a soluble fibre-enriched carbohydrate food study sponsored by Unity Health Toronto, investigating diabet…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Results of Tc99m-Maraciclatide Scintigraphy in Subjects With Diabetes Mellitus and Heart Failure With Preserved Left Ventricular Ejection Fraction [Phase 2]
Phase 2 trial evaluating Tc99m-Maraciclatide scintigraphy in adults with diabetes mellitus and heart failure with preserved ejection fractio…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE [Phase 3]
Phase 3 trial update for HDL-raising therapy using niacin with laropiprant; results posted in 2014 showed no reduction in major vascular eve…
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Long-term Study of TAK-875 [Phase 3]
TAK-875 (fasiglifam) from Takeda completed its long-term Phase 3 trial in diabetes mellitus. The update indicates the study status is COMPLE…
-
FDA approval · 2014-01-24FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro submitted by Eli Lilly and Company. The approval of the supplement indicates …
-
FDA approval · 2014-01-24FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly and Company. The approval updates the product's lab…